{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:09:05Z","timestamp":1788822545493,"version":"build-2803163510"},"reference-count":51,"publisher":"Georg Thieme Verlag KG","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, with its global prevalence projected to increase substantially by 2050, making its management one of the greatest challenges in respiratory medicine. Although pharmacological and nonpharmacological therapies remain the cornerstone of care, many patients continue to experience debilitating breathlessness, recurrent exacerbations, and impaired quality of life despite optimal medical treatment. Advances in interventional technology, imaging, patient selection, and anesthetic safety have transformed the therapeutic landscape, expanding the role of bronchoscopic and surgical interventions in the management of selected patients with COPD. These therapies aim to address the structural and pathophysiological consequences of disease that cannot be adequately treated with conventional medical therapy alone. Over the past three decades, lung volume reduction (LVR) has been extensively investigated and is now an established treatment option for appropriately selected patients with advanced emphysema. Both surgical and bronchoscopic LVR techniques have demonstrated improvements in lung function, exercise capacity, symptoms, and quality of life in carefully selected populations. Beyond LVR, a new generation of bronchoscopic therapies is emerging to target other COPD phenotypes and unmet clinical needs, including interventions designed to reduce exacerbation frequency, modify airway pathology, and improve symptom control. As the range of available treatment options continues to expand, multidisciplinary assessment and precision phenotyping are becoming increasingly important to identify the most appropriate intervention for each patient. This review provides an overview of the current evidence supporting established surgical and bronchoscopic LVR procedures and examines emerging bronchoscopic therapies for COPD. We discuss patient selection, procedural considerations, clinical outcomes, and future directions, highlighting the evolving role of interventional therapies within a personalized, multidisciplinary approach to COPD management.<\/jats:p>","DOI":"10.1055\/a-2935-5995","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:58:17Z","timestamp":1788821897000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Interventional and Surgical Therapies in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1055","author":[{"given":"Ashish","family":"Karir","sequence":"additional","affiliation":[{"name":"Imperial College London, England, United Kingdom","place":["London"],"department":["Airways Disease, National Heart and Lung Institute"]},{"name":"Royal Brompton Hospital, England, United Kingdom","place":["London"],"department":["Department of Interventional Pulmonology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-4638","authenticated-orcid":false,"given":"Pallav L.","family":"Shah","sequence":"additional","affiliation":[{"name":"Imperial College London, England, United Kingdom","place":["London"],"department":["Airways Disease, National Heart and Lung Institute"]},{"name":"Royal Brompton Hospital, England, United Kingdom","place":["London"],"department":["Department of Interventional Pulmonology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study","volume":"11","author":"S Chen","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"e002489","DOI":"10.1136\/bmjph-2024-002489","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2021: results from the Global Burden of Disease Study 2021","volume":"4","author":"Z Cao","year":"2026","journal-title":"BMJ Public Health"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"E Boers","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2020.02.023","article-title":"Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler","volume":"75","author":"C Sorino","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"477","key":"ref6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/pgmj.41.477.392","article-title":"The pathology of emphysema","volume":"41","author":"J Gough","year":"1965","journal-title":"Postgrad Med J"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(16)30221-1","article-title":"Lung volume reduction for emphysema","volume":"5","author":"P L Shah","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref8","first-page":"454","article-title":"Pathophysiology of emphysema and implications","volume":"3","author":"M Goldklang","year":"2016","journal-title":"Chronic Obstr Pulm Dis (Miami)"},{"key":"ref9","first-page":"187","article-title":"Pathogenesis of hyperinflation in chronic obstructive pulmonary disease","volume":"9","author":"P Gagnon","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-2600(18)30431-4","article-title":"Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis","volume":"7","author":"W H van Geffen","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"S 27","key":"ref11","doi-asserted-by":"crossref","first-page":"S3326","DOI":"10.21037\/jtd.2018.04.165","article-title":"History of lung volume reduction procedures","volume":"10","author":"A Marruchella","year":"2018","journal-title":"J Thorac Dis"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa030287","article-title":"A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema","volume":"348","author":"A Fishman","year":"2003","journal-title":"N Engl J Med"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"240107","DOI":"10.1183\/20734735.0107-2024","article-title":"Lung volume reduction: surgery versus endobronchial valves","volume":"20","author":"L J Ceulemans","year":"2024","journal-title":"Breathe (Sheff)"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/thoraxjnl-2013-203743","article-title":"Current status of bronchoscopic lung volume reduction with endobronchial valves","volume":"69","author":"P L Shah","year":"2014","journal-title":"Thorax"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa0900928","article-title":"A randomized study of endobronchial valves for advanced emphysema","volume":"363","author":"F C Sciurba","year":"2010","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/COPD.S103807","article-title":"The fissure: interlobar collateral ventilation and implications for endoscopic therapy in emphysema","volume":"11","author":"T D Koster","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000490733","article-title":"Chartis measurement of collateral ventilation: conscious sedation versus general anesthesia - a retrospective comparison","volume":"96","author":"J BA Welling","year":"2018","journal-title":"Respiration"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1164\/rccm.201707-1327OC","article-title":"A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM)","volume":"196","author":"S V Kemp","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201803-0590OC","article-title":"A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE)","volume":"198","author":"G J Criner","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/rccm.201902-0383OC","article-title":"Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial","volume":"200","author":"G J Criner","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/17476348.2020.1813571","article-title":"Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management","volume":"14","author":"T D Koster","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000490193","article-title":"Endobronchial coils for endoscopic lung volume reduction: best practice recommendations from an expert panel","volume":"96","author":"D J Slebos","year":"2018","journal-title":"Respiration"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-2600(13)70047-X","article-title":"Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial","volume":"1","author":"P L Shah","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"20","key":"ref24","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2016.6261","article-title":"Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial","volume":"315","author":"F C Sciurba","year":"2016","journal-title":"JAMA"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2015.17821","article-title":"Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial","volume":"315","author":"G Desl\u00e9e","year":"2016","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/COPD.S27312","article-title":"Bronchoscopic thermal vapor ablation in a canine model of emphysema","volume":"7","author":"S A Tuck","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000336239","article-title":"Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema","volume":"83","author":"D Gompelmann","year":"2012","journal-title":"Respiration"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1183\/09031936.00092411","article-title":"Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema","volume":"39","author":"G Snell","year":"2012","journal-title":"Eur Respir J"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2213-2600(16)00045-X","article-title":"Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial","volume":"4","author":"F J Herth","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"S 67","key":"ref30","first-page":"OA2593","article-title":"Bronchoscopic thermal vapor ablation (BTVA) in patients with severe upper lobe predominant emphysema: 36 months follow-up results from a prospective registry","volume":"62","author":"K Kontogianni","year":"2023","journal-title":"Eur Respir J"},{"key":"ref31","first-page":"335","article-title":"Technology update: bronchoscopic thermal vapor ablation for managing severe emphysema","volume":"7","author":"D Gompelmann","year":"2014","journal-title":"Med Devices (Auckl)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-11-1","article-title":"Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation","volume":"11","author":"P L Shah","year":"2011","journal-title":"BMC Pulm Med"},{"issue":"9795","key":"ref33","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(11)61050-7","article-title":"Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial","volume":"378","author":"P L Shah","year":"2011","journal-title":"Lancet"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1164\/rccm.202502-0378OC","article-title":"Airway scaffolds for emphysema-related hyperinflation: six-month results from the BREATHE trial","volume":"211","author":"A Tana","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"S 66","key":"ref35","first-page":"1231","article-title":"CONVERT trial: collateral ventilation conversion by closure of fissure defect with AeriSeal Foam for BLVR with Zephyr valves","volume":"60","author":"M Bezzi","year":"2022","journal-title":"Eur Respir J"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.chest.2022.02.005","article-title":"Bilateral bronchoscopic lung volume reduction after surgical fissure completion","volume":"162","author":"M Shafiq","year":"2022","journal-title":"Chest"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.chest.2022.09.032","article-title":"Bronchoscopic lung volume reduction after surgical fissure completion is not ready for prime time","volume":"163","author":"A Majid","year":"2023","journal-title":"Chest"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.53.2.129","article-title":"Structural and inflammatory changes in COPD: a comparison with asthma","volume":"53","author":"P K Jeffery","year":"1998","journal-title":"Thorax"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"2000556","DOI":"10.1183\/13993003.00556-2020","article-title":"A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD","volume":"56","author":"J L Garner","year":"2020","journal-title":"Eur Respir J"},{"issue":"S 68","key":"ref41","first-page":"OA2797","article-title":"Metered cryospray for the treatment of patients with chronic obstructive pulmonary disease with chronic bronchitis - Mechanism of action. A multicentre randomised controlled clinical trial","volume":"64","author":"C M Orton","year":"2024","journal-title":"Eur Respir J"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"e001710","DOI":"10.1136\/bmjresp-2023-001710","article-title":"Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx","volume":"10","author":"F C Sciurba","year":"2023","journal-title":"BMJ Open Respir Res"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MCP.0000000000001036","article-title":"Bronchoscopic interventions for chronic bronchitis","volume":"30","author":"A Tana","year":"2024","journal-title":"Curr Opin Pulm Med"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201908-1546OC","article-title":"Bronchial rheoplasty for treatment of chronic bronchitis. twelve-month results from a multicenter clinical trial","volume":"202","author":"A Valipour","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2147\/COPD.S464506","article-title":"Bronchial rheoplasty for chronic bronchitis: results from a Canadian feasibility study with RheOx","volume":"19","author":"M Fortin","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"aamag286.144","DOI":"10.1093\/ajrccm\/aamag286.144","article-title":"D30\u201319 Bronchial rheoplasty for chronic bronchitis: 24-month results from the Rhesolve study","volume":"212","author":"M G Lester","year":"2026","journal-title":"Am J Respir Crit Care Med"},{"issue":"9589","key":"ref47","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"J A Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/17476348.2024.2380070","article-title":"Small airways disease in chronic obstructive pulmonary disease","volume":"18","author":"N Lazarinis","year":"2024","journal-title":"Expert Rev Respir Med"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1152\/japplphysiol.00565.2018","article-title":"Physiologic and histopathologic effects of targeted lung denervation in an animal model","volume":"126","author":"J P Hummel","year":"2019","journal-title":"J Appl Physiol"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000500463","article-title":"Safety and dose study of targeted lung denervation in moderate\/severe COPD patients","volume":"98","author":"A Valipour","year":"2019","journal-title":"Respiration"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/COPD.S267409","article-title":"Two-year outcomes for the double-blind, randomized, sham-controlled study of targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2","volume":"15","author":"A Valipour","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1164\/rccm.201903-0624OC","article-title":"Safety and adverse events after targeted lung denervation for symptomatic moderate to severe chronic obstructive pulmonary disease (AIRFLOW). A multicenter randomized controlled clinical trial","volume":"200","author":"D J Slebos","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1164\/rccm.202502-0404OC","article-title":"Randomized sham-controlled trial of targeted lung denervation in patients with chronic obstructive pulmonary disease (AIRFLOW-3)","volume":"211","author":"P L Shah","year":"2025","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2935-5995.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:58:23Z","timestamp":1788821903000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2935-5995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1055\/a-2935-5995","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}